Skip to main content

MALARIA RESEARCH INSTITUTE

Leading Science for a Malaria-Free World 

Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere. 

The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.

News and Noteworthy

Matt Ippolito Euro News

In the News

As US faces rare EEE cases, which mosquito-borne diseases are rising in Europe? Matt Ippolito, MD, is quoted.

Time Magazine Photini Sinnis

In the News

Why Mosquitoes Are So Dangerous Right Now. Photini Sinnis, MD, is quoted.

David Sullivan in Web MD

In the News

Lancet

Newly Published

Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum | Moss Lab

Cell Reports Dimopoulos Lab

Newly Published

Anopheles gambiae lacking AgTRIO probe inefficiently on a mammalian host | Dimopoulos Lab

Journal of Biological Chemistry

Newly Published

The major surface protein of malaria sporozoites is GPI-anchored to the plasma membrane | Sinnis Lab

130+

 Pilot grants awarded

750+

First- and last-authored publications since 2010 

Malaria Research 

Watch the video to learn how scientists at the Johns Hopkins Malaria Research Institute research malaria from the lab in Baltimore to the field in Southern and Central Africa.